Skip Page Header

Home > Biomedical risk assessment as an aid for smoking cessation.

Clair, Carole and Mueller, Yolanda and Livingstone‐Banks, Jonathan and Burnand, Bernard and Camain, Jean Yves and Cornuz, Jacques and Rège Walther, Myriam and Selby, Kevin and Bize, Raphaël [The Cochrane Library] . (2019) Biomedical risk assessment as an aid for smoking cessation. London: John Wiley & Sons, Ltd. Cochrane Database of Systematic Reviews (3) Art. No.: CD004705. DOI: 10.1002/14651858.CD004705.pub5.


There is little evidence about the effects of biomedical risk assessment as an aid for smoking cessation. The most promising results relate to spirometry and carotid ultrasound, where moderate‐certainty evidence, limited by imprecision and risk of bias, did not detect a statistically significant benefit, but confidence intervals very narrowly missed one, and the point estimate favoured the intervention. A sensitivity analysis removing those studies at high risk of bias did detect a benefit. Moderate‐certainty evidence limited by risk of bias did not detect an effect of feedback on smoking exposure by CO monitoring. Low‐certainty evidence, limited by risk of bias and imprecision, did not detect a benefit from feedback on smoking‐related risk by genetic marker testing. There is insufficient evidence with which to evaluate the hypothesis that multiple types of assessment are more effective than single forms of assessment.

Item Type
Evidence resource
Publication Type
Drug Type
Intervention Type
AOD disorder treatment method, AOD disorder harm reduction, Psychosocial treatment method, Rehabilitation/Recovery
March 2019
John Wiley & Sons, Ltd
Place of Publication
Accession Number
HRB (Not in collection)

Repository Staff Only: item control page